TSPAN32 suppresses chronic myeloid leukemia pathogenesis and progression by stabilizing PTEN.

Qiu Q, Sun Y, Yang L, Li Q, Feng Y, Li M, Yin Y, Zheng L, Li N, Qiu H, et al. TSPAN32 suppresses chronic myeloid leukemia pathogenesis and progression by stabilizing PTEN. Signal Transduct Target Ther. 2023;8(1):90.